血流储备分数指导的急性心肌梗死多支血管成形术
该随机对照试验纳入885例STEMI合并多支血管病变、已行梗死相关动脉直接PCI的患者,按1:2随机分为FFR指导的非梗死相关动脉完全血运重建组(295例)与仅处理梗死相关动脉组(590例)。两组均行FFR检查,但后者患者与心内科医生均对FFR结果不知情。主要终点为12个月全因死亡、非致死性心肌梗死、血运重建和脑血管事件的复合终点。完全血运重建组主要终点事件23例(每100例8例事件),仅梗死动脉组121例(每100例21例事件),HR 0.35(95%CI 0.22–0.55,P<0.001),该获益主要由后续血运重建减少驱动。
要点
- STEMI多支血管病变患者直接PCI后,急性期行FFR指导的非梗死相关动脉完全血运重建,12个月复合心血管终点事件每100例8例 vs 仅梗死动脉组每100例21例(HR 0.35,95%CI 0.22–0.55,P<0.001)。
- 全因死亡完全血运重建组4例 vs 仅梗死动脉组10例(1.4% vs 1.7%,HR 0.80,95%CI 0.25–2.56)。
- 心肌梗死完全血运重建组7例 vs 仅梗死动脉组28例(2.4% vs 4.7%,HR 0.50,95%CI 0.22–1.13)。
- 血运重建完全血运重建组18例 vs 仅梗死动脉组103例(6.1% vs 17.5%,HR 0.32,95%CI 0.20–0.54)。
- 脑血管事件完全血运重建组0例 vs 仅梗死动脉组4例(0 vs 0.7%);FFR相关严重不良事件2例,均发生在仅梗死相关动脉治疗组。
适用人群与场景
- STEMI合并多支血管病变、已行梗死相关动脉直接PCI的患者。
- 研究纳入885例,随机分为FFR指导完全血运重建组295例与仅梗死相关动脉治疗组590例。
诊断标准与关键阈值
- 主要终点为12个月全因死亡、非致死性心肌梗死、血运重建和脑血管事件的复合终点。
- 仅梗死相关动脉治疗组中,直接PCI后45天内临床指征明确的择期血运重建不计为事件。
处置流程与药物剂量
- 两组均行FFR检查;仅梗死相关动脉治疗组患者与心内科医生均对FFR结果不知情。
- FFR指导完全血运重建组在急性期对非梗死相关动脉行FFR指导的完全血运重建。
- 仅梗死相关动脉治疗组仅处理梗死相关动脉,不处理非梗死相关动脉。
研究设计与关键结果
- 研究为随机对照试验,纳入885例STEMI合并多支血管病变、已行梗死相关动脉直接PCI的患者,按1:2随机分为FFR指导完全血运重建组(295例)与仅梗死相关动脉治疗组(590例)。
- 主要终点12个月复合心血管事件:完全血运重建组23例(每100例8例事件)vs 仅梗死动脉组121例(每100例21例事件),HR 0.35(95%CI 0.22–0.55,P<0.001)。
- 全因死亡:完全血运重建组4例 vs 仅梗死动脉组10例(1.4% vs 1.7%),HR 0.80(95%CI 0.25–2.56)。
- 非致死性心肌梗死:完全血运重建组7例 vs 仅梗死动脉组28例(2.4% vs 4.7%),HR 0.50(95%CI 0.22–1.13)。
- 血运重建:完全血运重建组18例 vs 仅梗死动脉组103例(6.1% vs 17.5%),HR 0.32(95%CI 0.20–0.54)。
- 脑血管事件:完全血运重建组0例 vs 仅梗死动脉组4例(0 vs 0.7%)。
- FFR相关严重不良事件2例,均发生在仅梗死相关动脉治疗组。
- 作者结论:急性期FFR指导的非梗死相关动脉完全血运重建使复合心血管结局风险低于仅治疗梗死相关动脉,该发现主要由后续血运重建减少所支持。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 试验注册:Compare-Acute,ClinicalTrials.gov编号NCT01399736;由Maasstad Cardiovascular Research等资助。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于STEMI合并多支血管病变且已行梗死相关动脉直接PCI的患者,作者认为在急性期加用FFR指导的非梗死相关动脉完全血运重建,可使复合心血管结局风险低于仅治疗梗死相关动脉。
- 该获益主要由后续血运重建减少所支持;全因死亡、心肌梗死和脑血管事件的HR置信区间均跨1,未达统计学显著。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to restore blood flow in an infarct-related coronary artery improves outcomes. The use of PCI in non-infarct-related coronary arteries remains controversial.
METHODS: We randomly assigned 885 patients with STEMI and multivessel disease who had undergone primary PCI of an infarct-related coronary artery in a 1:2 ratio to undergo complete revascularization of non-infarct-related coronary arteries guided by fractional flow reserve (FFR) (295 patients) or to undergo no revascularization of non-infarct-related coronary arteries (590 patients). The FFR procedure was performed in both groups, but in the latter group, both the patients and their cardiologist were unaware of the findings on FFR. The primary end point was a composite of death from any cause, nonfatal myocardial infarction, revascularization, and cerebrovascular events at 12 months. Clinically indicated elective revascularizations performed within 45 days after primary PCI were not counted as events in the group receiving PCI for an infarct-related coronary artery only.
RESULTS: The primary outcome occurred in 23 patients in the complete-revascularization group and in 121 patients in the infarct-artery-only group that did not receive complete revascularization, a finding that translates to 8 and 21 events per 100 patients, respectively (hazard ratio, 0.35; 95% confidence interval [CI], 0.22 to 0.55; P<0.001). Death occurred in 4 patients in the complete-revascularization group and in 10 patients in the infarct-artery-only group (1.4% vs. 1.7%) (hazard ratio, 0.80; 95% CI, 0.25 to 2.56), myocardial infarction in 7 and 28 patients, respectively (2.4% vs. 4.7%) (hazard ratio, 0.50; 95% CI, 0.22 to 1.13), revascularization in 18 and 103 patients (6.1% vs. 17.5%) (hazard ratio, 0.32; 95% CI, 0.20 to 0.54), and cerebrovascular events in 0 and 4 patients (0 vs. 0.7%). An FFR-related serious adverse event occurred in 2 patients (both in the group receiving infarct-related treatment only).
CONCLUSIONS: In patients with STEMI and multivessel disease who underwent primary PCI of an infarct-related artery, the addition of FFR-guided complete revascularization of non-infarct-related arteries in the acute setting resulted in a risk of a composite cardiovascular outcome that was lower than the risk among those who were treated for the infarct-related artery only. This finding was mainly supported by a reduction in subsequent revascularizations. (Funded by Maasstad Cardiovascular Research and others; Compare-Acute ClinicalTrials.gov number, NCT01399736 .).
参考来源
- Smits PC, Abdel-Wahab M, Neumann FJ, et al. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. N Engl J Med. 2017. PMID: 28317428. doi:10.1056/NEJMoa1701067
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。